Opportunities in proximity modulation: Bridging academia and industry
Molecular Cell · 2025-08 · 85 (16) · 3012-3022
DOI: 10.1016/j.molcel.2025.07.018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Cell, 2025-08. Verfasst von Ivan Dikic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry II, Medical Faculty, Goethe University, 60596 Frankfurt am Main, Germany; Max Planck Institute of Biophysics, 60439 Frankfu…. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Ubiquitin, Drug Industry. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, Merck KGaA.
Abstract (Originalsprache)
In the past decade, exciting therapeutic strategies to harness the ubiquitin-proteasome system (UPS) for degradation of target proteins have emerged. Proximity-inducing modalities are at the center of these strategies and act by modulating protein-protein interactions. While we are still learning to harvest this approach, it holds tremendous promise for developing treatments for hitherto undruggable proteins. Here, we discuss how academic efforts and academic-industrial collaboration have advanced the development of therapeutic modalities based on the principle of proximity induction. We make a case for forming a global academia-industry alliance to enhance access to training and expertise while accelerating innovation and translation from ground-breaking ideas to proof of concept in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry II, Medical Faculty, Goethe University, 60596 Frankfurt am Main, Germany; Max Planck Institute of Biophysics, 60439 Frankfurt am Main, Germany; Fraunhofer Institute for Translational Medicine a…
- Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain. Electronic address: cristina.mayor-ruiz@irbbarcelona.org.
- CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; AITHYRA-Research Institute for Biomedical Artificial Intelligence, 1030 Vienna, Austria. Electronic address: gwinter…
- Institute of Biochemistry II, Medical Faculty, Goethe University, 60596 Frankfurt am Main, Germany. Electronic address: k.koch@em.uni-frankfurt.de.
- Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, DD1 5JJ Dundee, UK. Electronic address: a.ciulli@dundee.ac.uk.
- EPFL, School of Life Science and Institute of Experimental Cancer Research (ISREC), Station 19, 1015 Lausanne, Switzerland. Electronic address: nicolas.thoma@epfl.ch.
Förderung
- Pfizer
- Merck KGaA
Zitieren
APA
Dikic, I., Mayor-Ruiz, C., Winter, G. E., Koch, K., Ciulli, A., & Thomä, N. H. (2025). Opportunities in proximity modulation: Bridging academia and industry. Molecular Cell, 85(16), 3012-3022. https://doi.org/10.1016/j.molcel.2025.07.018
Vancouver
Dikic I, Mayor-Ruiz C, Winter GE, Koch K, Ciulli A, Thomä NH. Opportunities in proximity modulation: Bridging academia and industry. Molecular Cell. 2025;85(16):3012-3022. doi:10.1016/j.molcel.2025.07.018
BibTeX
@article{Dikic2025,
author = {Dikic, Ivan and Mayor-Ruiz, Cristina and Winter, Georg E and Koch, Kerstin and Ciulli, Alessio and Thomä, Nicolas H},
title = {Opportunities in proximity modulation: Bridging academia and industry},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {16},
pages = {3012--3022},
doi = {10.1016/j.molcel.2025.07.018}
}
EUVIMED